Michelle L. Hastings
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
100
Citations
6,264
Est. group size
~1
Recurring co-author estimate
Active years
30
Publishing since 1997
Typically publishes in teams of ~7 · 14% small-team papers (≤3 authors) · across 29 venues
- Variant-selective RNA-targeting small molecules partially restore CFTR W1282X function in Cystic Fibrosis
Research Square · 2026
- Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease
Nucleic Acids Research · 2025
- Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation
Nucleic Acids Research · 2025
- Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- 245 Uncovering the regulatory roles of CFTR UTRs for enhanced expression via antisense oligonucleotides
Journal of Cystic Fibrosis · 2025
- Elevating microRNA levels by targeting biogenesis with steric-blocking antisense oligonucleotides
RNA · 2024
- Systematic deletion of symmetrical <i>CFTR</i> exons reveals new therapeutic targets for exon skipping antisense oligonucleotides
NAR Molecular Medicine · 2024
- Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Systematic deletion of symmetrical <i>CFTR</i> exons reveals new therapeutic targets for exon skipping antisense oligonucleotides
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- 259 Splice-switching antisense oligonucleotides to recover CFTR function disrupted by C-terminal truncating nucleotide variants
Journal of Cystic Fibrosis · 2024
- 275 Evaluating rare CFTR variants for therapeutic intervention with antisense oligonucleotides
Journal of Cystic Fibrosis · 2024
- RNA therapeutics
RNA · 2023
- Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach
Molecular Therapy — Nucleic Acids · 2023
- Viral-like TLR3 induction of cytokine networks and α-synuclein are reduced by complement C3 blockade in mouse brain
Scientific Reports · 2023
- 243 Splice-switching antisense oligonucleotides for the treatment of Class I CFTR mutations
Journal of Cystic Fibrosis · 2023
- Nucleic Acids Research×6
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Journal of Cystic Fibrosis×6
- Human Molecular Genetics×3
- Molecular Therapy×2
- Caleb M. Embree
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Lauren A. Woodward
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Guoming Gao
Biochemistry, Genetics and Molecular Biology · University of Michigan
- David J. Elliott
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Maria C. Sterrett
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile